JAK/STAT pathway inhibitors (National University of Singapore)

N/A

Report date: 2025/03/20 16:12:16
NME

Base Information

Drug NameJAK/STAT pathway inhibitors (National University of Singapore)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitorsSTAT transcription factors inhibitors
TargetsJanus kinaseSTAT transcription factors
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational University Of Singapore
China Registration ClassN/A

Develop Information

Active CompaniesNational University Of Singapore
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A